4.5 Article

The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice

Journal

FEBS LETTERS
Volume 594, Issue 20, Pages 3324-3337

Publisher

WILEY
DOI: 10.1002/1873-3468.13903

Keywords

B1 cells; histone methylation; MMSET; NSD2

Funding

  1. NIH [AI118891, CA196539]
  2. Leukemia and Lymphoma Robert Arceci Scholar Award
  3. International Myeloma Foundation
  4. Wendy Will Case Cancer Fund
  5. Open Philanthropy Project/Good Ventures Fund
  6. GlaxoSmithKline
  7. NATIONAL CANCER INSTITUTE [P01CA196539] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Humoral immunity in mammals relies on the function of two developmentally and functionally distinct B-cell subsets-B1 and B2 cells. While B2 cells are responsible for the adaptive response to environmental antigens, B1 cells regulate the production of polyreactive and low-affinity antibodies for innate humoral immunity. The molecular mechanism of B-cell specification into different subsets is understudied. In this study, we identified lysine methyltransferase NSD2 (MMSET/WHSC1) as a critical regulator of B1 cell development. In contrast to its minor impact on B2 cells, deletion of the catalytic domain of NSD2 in primary B cells impairs the generation of B1 lineage. Thus, NSD2, a histone H3 K36 dimethylase, is the first-in-class epigenetic regulator of a B-cell lineage in mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available